Comparison of the Euroimmun Borrelia ‘antibody index’ with Virotech immunoblot-based detection of intrathecal Borrelia antibody production for the diagnosis of Lyme neuroborreliosis

[1]  F. C. Knudtzen,et al.  The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[2]  B. Pritt,et al.  Limitations and Confusing Aspects of Diagnostic Testing for Neurologic Lyme Disease in the United States , 2018, Journal of Clinical Microbiology.

[3]  B. H. Skogman,et al.  The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  R. Dessau,et al.  The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis , 2016, BMC Infectious Diseases.

[5]  F. Fazekas,et al.  Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: Comparison of two ELISAs, immunoblot and CXCL13 testing , 2014, Journal of the Neurological Sciences.

[6]  F. Strle,et al.  Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis , 2014, Medical Microbiology and Immunology.

[7]  A. Matussek,et al.  Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  M. Djukic,et al.  Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis , 2011, Journal of Neurology.

[9]  F. Strle,et al.  Humoral Immune Responses in Patients with Lyme Neuroborreliosis , 2010, Clinical and Vaccine Immunology.

[10]  V. Fingerle,et al.  EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis , 2010, European journal of neurology.

[11]  M. Cimmino,et al.  Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe , 1998, Infection.

[12]  E. Ferenczi,et al.  Different B-cell populations are responsible for the peripheral and intrathecal antibody production in neuroborreliosis. , 2005, International immunology.

[13]  V. Fingerle,et al.  Improvement of Lyme Borreliosis Serodiagnosis by a Newly Developed Recombinant Immunoglobulin G (IgG) and IgM Line Immunoblot Assay and Addition of VlsE and DbpA Homologues , 2005, Journal of Clinical Microbiology.

[14]  J. Piesman,et al.  Lyme borreliosis in Europe and North America , 2004, Parasitology.

[15]  Barbara J. B. Johnson,et al.  Significant Improvement of the Recombinant Borrelia-Specific Immunoglobulin G Immunoblot Test by Addition of VlsE and a DbpA Homologue Derived from Borrelia garinii for Diagnosis of Early Neuroborreliosis , 2003, Journal of Clinical Microbiology.

[16]  L. Moravcová,et al.  Clinical Comparison of Immunoblot and Antibody Index for Detection of Intrathecal Synthesis of Specific Antibodies in Lyme Neuroborreliosis , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[17]  B. Luft,et al.  Lyme borreliosis. , 1994, International journal of antimicrobial agents.